Literature DB >> 9147184

Restrictive strabismus after retrobulbar anesthesia.

K Ando1, A Oohira, M Takao.   

Abstract

Two rare cases of strabismus resulting from contracture of the extraocular rectus muscles after retrobulbar anesthesia for cataract surgery are described. Clinical signs in both cases suggested that the development of the impaired function of the lateral and superior rectus muscles followed the same pattern: initial stimulation followed by paretic and restrictive stages. Abnormal enlargement of the muscles was identified by computed tomography (CT) and magnetic resonance imaging (MRI). The data indicate that the strabismus was the result of direct injection of anesthetics into the rectus muscle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9147184     DOI: 10.1016/s0021-5155(96)00003-2

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  4 in total

1.  Comparing the preventive effect of 2 percent topical lidocaine and intravenous atropine on oculocardiac reflex in ophthalmological surgeries under general anesthesia.

Authors:  Parvin Sajedi; Maryam Soleymani Nejad; Kamran Montazeri; Elahe Baloochestani
Journal:  Int J Prev Med       Date:  2013-11

2.  Adjunctive Local Application of Lidocaine during Scleral Buckling under General Anesthesia.

Authors:  Alireza Dehghani; Kamran Montazeri; Amin Masjedi; Najmeh Karbasi; Leila Ashrafi; Behrooz Saeedian
Journal:  J Ophthalmic Vis Res       Date:  2011-07

3.  A comparison of topical or retrobulbar anesthesia for 23-gauge posterior vitrectomy.

Authors:  Hande Celiker; Levent Karabas; Ozlem Sahin
Journal:  J Ophthalmol       Date:  2014-11-18       Impact factor: 1.909

4.  Feasibility and safety of vitrectomy under topical anesthesia in an office-based setting.

Authors:  Gloria Paulina Trujillo-Sanchez; Alejandro Gonzalez-De La Rosa; Jose Navarro-Partida; Luis Haro-Morlett; Juan Carlos Altamirano-Vallejo; Arturo Santos
Journal:  Indian J Ophthalmol       Date:  2018-08       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.